Silent epidemic of childhood bronchiectasis in Pakistan: An infectious disease physician\u27s perspective by Mir, Fatima
eCommons@AKU 
Department of Paediatrics and Child Health Division of Woman and Child Health 
1-27-2021 
Silent epidemic of childhood bronchiectasis in Pakistan: An 
infectious disease physician's perspective 
Fatima Mir 
Aga Khan University, fatima.mir@aku.edu 
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr 
 Part of the Infectious Disease Commons, and the Maternal and Child Health Commons 
Recommended Citation 
Mir, F. (2021). Silent epidemic of childhood bronchiectasis in Pakistan: An infectious disease physician's 
perspective. EBioMedicine, 64, 103221. 
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/989 
Letter
Silent epidemic of childhood bronchiectasis in Pakistan: An infectious
disease physician's perspective
Fatima Mir*
Associate Professor, Department of Paediatrics and Child Health, the Aga Khan University, Karachi, Sindh 74800, Pakistan
A R T I C L E I N F O
Article History:
Received 1 January 2021
Accepted 8 January 2021
Available online 28 January 2021
Resource-poor countries like Pakistan, which have a high burden
of childhood pneumonia and under 5 pneumonia mortality, are still
grappling with lifelong consequences of pneumonia, like paediatric
bronchiectasis [1,2]. Infants and young children cannot use diagnostic
and prognostic resources (laboratories, radiology) available to adults
with chronic lung disease in Pakistan with ease. They require addi-
tional support such as sedation during procedures, age-appropriate
laboratory cut-offs, child-friendly spirometry, and molecular tests for
relevant primary disorders (cystic fibrosis/inherited or acquired
immune deficiency/Kartageners Syndrome). Diagnostic limitations
have contributed to an under-estimation of the burden of childhood
bronchiectasis in Pakistan [3]. A national registry of bronchiectasis
(adult and paediatric) is also lacking [4], which could benefit patients
and streamline the need for specialised treatments or transplantation.
Pakistan lacks a sufficient number of paediatric pulmonologists
and has very few paediatric respiratory therapists at present. As a
paediatric infectious disease physician, I began receiving referrals for
children with bronchiectasis and impending respiratory failure in
2014. Families were mostly in denial about why their children were
chronically unwell. They were not aware of the importance of effi-
cient and regular pulmonary hygiene, or the different care required
in well versus sick days. Aggressive management at a possibly too-
late timepoint was difficult to implement. Parents would not consent
to necessary interventions like indwelling intravenous lines, feeding
tubes and/or diagnostic bronchoalveolar lavage as they were per-
ceived as too invasive. Providing broad spectrum antibiotics through
peripheral lines and nutritional rehabilitation by mouth to a sick
child with respiratory distress was invariably unproductive. There
was also no capacity to supervise home bilevel positive airway pres-
sure and end of life care to children with air-hunger at that time.
Each missing link in the chain of care in Pakistan (affordable diagnos-
tics, patient and parent education, effective nutritional rehabilitation,
optimised pulmonary hygiene, management of chronic pulmonary
colonisation and acute pulmonary exacerbations, social support for
affected children and their families, monitoring of quality of life, and
access to end of life care and palliative services) is already a recog-
nised research priority [5].
Over time, a team of in-house experts (respiratory therapist,
general paediatrician with respiratory interest, geneticist, infec-
tious disease physician, gastroenterologist/nutritionist, endocrinol-
ogist, intensivist, adult pulmonologist, microbiologist) have come
together at the Aga Khan University (AKU) Karachi and treated
multiple children with bronchiectasis. We now understand that
the 250 plus children with Bronchiectasis seen at AKU are not
accounted for by cystic fibrosis alone. Although there is a fair share
of post tuberculosis and inherited immune deficiency, there are
also many without pre-existing conditions and a history of recur-
rent pneumonia alone.
Given the paucity of paediatric pulmonologists in the country,
chronic lung infections are generally dealt with by general paediatri-
cians, who may not be optimally equipped to escalate care, or by a
small number of paediatric infectious disease physicians. Training
programs in paediatric infectious disease, critical care, endocrinology,
and now Respiratory Therapy at AKU are new sources of hope as they
are beginning to create a group of experts who can formalise team
approach, develop and disseminate customised guidelines for care in
Pakistan of children with bronchiectasis using academic forums like
Pakistan Paediatric Association.
Our roadmap for formalising care of children with bronchiectasis
includes creating a paediatric bronchiectasis registry at AKU which
will not only provide a base for effective indigenous research output
but also allow development of a Paediatric Respiratory Care Program
through a Karachi-based childrens’ hospitals sisterhood (AKU/
National Institute of Child Health/The Indus Hospital Network). We
hope this can provide a proof of concept for similar private-public
health institution partnerships across the country, committed to
improving survival and quality of life for children and parents dealing
with childhood bronchiectasis.
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